Inari Shares Skyrocket

Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B
Key Takeaways Shares of Inari Medical surged Monday afternoon and again Tuesday morning as reports of an imminent acquisition by Stryker turned into reality.Stryker will acquire Inari in an all-cash deal for $80 per share,
Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion
Stryker has agreed to acquire medical technology maker Inari Medical in a deal worth $4.9 billion, the companies said Monday.The medical device maker plans to buy all of Inari’s common stock for $80 a share,
Stryker Buying Inari Medical in $4.9B Deal to Boost Vascular Business
Medical device maker Stryker said it has reached a deal to acquire Inari Medical for $80 per share in cash, representing an approximate value of $4.9 billion.
Stryker strikes $4.9B deal to buy Inari Medical
Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at $4.9 billion.
Inari Medical soars on report of Stryker talks
Inari Medical's stock surged 6% amid reports of advanced acquisition talks with Stryker, potentially closing a deal this week.
Stryker to acquire Inari Medical for $4.9B
Stryker said its planned acquisition of Inari Medical would strengthen its position in the peripheral vascular market.
Here’s Why Inari Medical Inc. (NASDAQ:NARI) Is Skyrocketing
We recently compiled a list of the Investor Optimism Boosts Jump of These 10 Stocks. In this article, we are going to take a look at where Inari Medical Inc. (NASDAQ:NARI) stands against the other stocks.
Inari Medical (NARI) was downgraded to a Hold Rating at BTIG
Inari Medical (NARI – Research Report) received a Hold rating and price target from BTIG analyst Marie Thibault today. The company’s shares
William Blair Downgrades Inari Medical (NARI)
Fintel reports that on January 7, 2025, William Blair downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Outperform to Market Perform. Analyst Price Forecast Suggests 14.20% Downside As of December 23,
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a ...
Hold Rating Issued for Inari Medical Amidst Stryker Acquisition with Minimal Antitrust Concerns and Reasonable Valuation
Inari Medical (NARI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Sarcone ...
5 Things to Know Before the Stock Market Opens
U.S. stock futures are little changed after indexes were mixed Monday; Nvidia stock adds to all-time high after CEO comments; ...
Medical device maker Stryker nearing a deal to buy Inari Medical, sources say
A deal for Inari, which has a market value of nearly $3 billion, would bolster Stryker’s efforts to build out its offerings ...
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Inari Medical, Inc. Buyout
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities ...
These Stocks Are Moving the Most Today: Nvidia, Micron, Uber, FuboTV, Inari Medical, Denali Therapeutics, and More
Nvidia stock rises after the artificial-intelligence chip maker unveils its next generation gaming graphic cards, while ...